Peer Review activities

I have been asked to act as a reviewer for the first time about four years ago and since then I have made more than 60 reviews. Nowadays each one of us is always full of commitments and under pressure but despite that I always try to find some time to review manuscripts and/or proposals. Every time I receive a request for revision, I consider it a sign of esteem, especially because the Editors normally select the reviewers base on the “area of expertise”; from another hand, each review represents a moment of both reflection and intellectual growth that can broaden the reviewer’s point of view.

Topical Advisoy Panel Member

International Journal of Molecular Sciences | Journal

Feb 2022– Present

Molecules | Journal

Gen 2019 – Present

Editorial Board member

Neuroglia | Journal

Feb 2021 – Present

Associate Editor For

Frontiers in Neuroscience | Neurodegeneration

Feb 2021 – Present

Review Editor For

Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery

Apr 2021 – Present

Frontiers in Neuroscience | Neuroenergetics, Nutrition and Brain Health

Apr 2017 – Present

Frontiers in Psychiatry | Molecular Psychiatry

Oct 2020– Present

Verified reviews for

Visit my Publons profile for more detail regarding my peer review activities.

Reviewer for

French National Research Agency’s (ANR) | Generic Call for Proposals 2020 (AAPG 2020)

Jun 2020

Guest Editor

Molecules |

Special Issue: “The Therapeutic Potential of Naturally Occurring Compounds in Counteracting Oxidative Stress and Inflammation: From Basic Science to Therapy 2.0”

Nov 2022 – Present

Frontiers in Pharmacology

Research Topic: “Microfluidics and Mass Spectrometry in Drug Discovery and Development: From Synthesis to Evaluation”

June 2022 – Present

Molecules | Direct link

Special Issue: “The Therapeutic Potential of Naturally Occurring Compounds in Counteracting Oxidative Stress and Inflammation: From Basic Science to Therapy”

Nov 2019 – Feb 2022

International Journal of Molecular Sciences | Direct link

Special Issue: “Antioxidant Therapies in Acute and Chronic Neurodegenerations”

Apr 2021 – Present